Evaluation of Screening Methods for Treatment of Meibomian Gland Dysfunction

Completed · Phase 2/Phase 3

Conditions studied: Chalazion, Dry Eye Syndromes

In brief

The objective is to evaluate the feasibility of using additional screening methods to optimize effectiveness outcomes with the LipiFlow System for application of heat and pressure therapy in adult patients with chronic cystic conditions of the eyelids, including meibomian gland dysfunction, also known as evaporative dry eye or lipid deficiency dry eye, and chalazia. The screening methods include diagnostic expression of the meibomian glands and interferometry assessment of the tear film.

Key facts

Study ID

NCT01202747

Run by

TearScience, Inc.

People needed

50

Starts

2010-09-01

Expected to finish

2011-01-01

Last updated by the study team

2011-12-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Meibomian gland dysfunction
• Dry Eye symptoms

You may not qualify if…

• Ocular surgery, ocular injury or ocular Herpes infection within past 3 months
• Active ocular infection
• Active ocular inflammation or recurrent inflammation within past 3 months
• Moderate to severe allergic conjunctivitis
• Severe eyelid inflammation
• Eyelid abnormalities that affect lid function
• Ocular surface abnormalities that may compromise corneal integrity
• Systemic disease conditions or medications that cause dry eye
• Use of other treatments for meibomian gland dysfunction or dry eye
• Pregnant or nursing women
• Participation in another ophthalmic clinical trial within past 30 days

Where it is running

• Study site — Hoffman Estates, Illinois, United States
• Study site — Boston, Massachusetts, United States
• Study site — Winchester, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.